James S. Scibetta, President at Pacira Pharmaceuticals, Inc. (PCRX), sold 25,000 shares at $45.21 ($1.1M) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Open-market sale of $1.1M PCRX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |